Low treatment rates in patients meeting guideline criteria in diverse practice settings (Q42203889)

18 October 2017

Low treatment rates in patients meeting guideline criteria in diverse practice settings (English)

1 reference

18 October 2017

Lily H Kim

1

1 reference

18 October 2017

Vincent G Nguyen

2

1 reference

18 October 2017

Huy N Trinh

3

1 reference

18 October 2017

Jiayi Li

4

1 reference

18 October 2017

Jian Q Zhang

5

1 reference

18 October 2017

Mindie H Nguyen

6

1 reference

18 October 2017

25 July 2014

1 reference

Digestive Diseases and Sciences

18 October 2017

1 reference

18 October 2017

59

1 reference

18 October 2017

9

1 reference

18 October 2017

2091-2099

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-014-3283-3

18 October 2017

0 references

cites work

Factors associated with response to lamivudine: Retrospective study in a tertiary care clinic serving patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Hepatitis B in the United States: a major health disparity affecting many foreign-born populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Global epidemiology of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Natural history of chronic hepatitis B REVEALed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Health state utilities and quality of life in patients with hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Review article: current antiviral therapy of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Undertreatment of Asian chronic hepatitis B patients on the basis of standard guidelines: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Is chronic hepatitis B being undertreated in the United States?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

The prevalence and clinical correlates of elevated ALT levels in an urban Chinatown community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Hepatitis B: reflections on the current approach to antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

The patient, the doctor, and the system: underdiagnosis and undertreatment of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Epidemiology of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3283-3

Chronic hepatitis B: perceptions in Asian American communities and diagnosis and management practices among primary care physicians

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25060778

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Underestimation of chronic hepatitis B virus infection in the United States of America

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25060778

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10620-014-3283-3

1 reference

18 October 2017

1 reference